How do corticosteroids (CS) affect protein metabolism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Corticosteroids Cause Increased Protein Catabolism

Corticosteroids significantly increase protein breakdown and loss, causing a net negative protein balance that leads to muscle wasting and altered body composition. 1, 2

Mechanism of Corticosteroid-Induced Protein Catabolism

Corticosteroids affect protein metabolism through several mechanisms:

  1. Increased Protein Breakdown:

    • Corticosteroids stimulate ubiquitin-proteasome-dependent proteolysis in skeletal muscle 3
    • They increase the rates of appearance of amino acids (phenylalanine and leucine), reflecting accelerated protein degradation 4, 2
    • In children with Crohn's disease, corticosteroid therapy increased protein breakdown by 26-32% 2
  2. Increased Protein Loss:

    • Corticosteroids significantly increase urea production (up to 273% in some studies), indicating greater protein loss 2
    • They cause increased efflux of multiple amino acids from muscle tissue, including phenylalanine, asparagine, arginine, alanine, methionine, and isoleucine 4
  3. Potential Impact on Protein Synthesis:

    • Corticosteroids can reduce polyribosomes by approximately 6%, suggesting a decreased capacity for protein synthesis 4
    • However, the effect on actual protein synthesis rates is less consistent across studies 5, 4

Clinical Implications

In Inflammatory Bowel Disease (IBD)

  • Corticosteroids increase net protein loss in both children 2 and adults 6 with Crohn's disease
  • This contributes to the relative reduction in lean mass and increase in adiposity observed in IBD patients over time 6
  • Protein requirements are increased during active IBD (1.2-1.5 g/kg/day recommended) to compensate for this catabolic effect 6

In Other Clinical Contexts

  • Corticosteroid-induced protein catabolism affects predominantly type 2 muscle fibers (fast-twitch), leading to selective wasting of certain muscle groups 7
  • This can lead to steroid myopathy, characterized by proximal muscle weakness
  • Prolonged corticosteroid use contributes to osteoporosis and vertebral compression fractures due to protein loss from bone matrix 6

Management Strategies

  1. Increased Protein Intake:

    • During corticosteroid therapy, protein intake should be increased to 1.2-1.5 g/kg/day 6
    • This helps compensate for the increased protein breakdown and loss
  2. Nutritional Support:

    • In patients receiving steroids, enteral tube feeding may provide beneficial effects on protein turnover 6
    • Monitoring of anthropometry helps identify patients who develop deficits in lean mass 6
  3. Avoid Unnecessary Diet Restrictions:

    • In patients on systemic corticosteroid therapy, salt, sugar, fat, or calorie reduction should not be recommended as the benefit-risk ratio is unfavorable toward a higher risk for malnutrition 6
    • A standard diet should be proposed to cover increased energy expenditure and protein catabolism 6

Special Considerations

  • The catabolic effects of corticosteroids may be more pronounced in certain populations, such as children with chronic diseases 6
  • The interaction between corticosteroids and inflammatory cytokines can further exacerbate protein breakdown in conditions like sepsis 3
  • Short-term, moderate-dose prednisone may not significantly affect protein metabolism in healthy individuals, but longer-term or higher-dose therapy typically does 5

By understanding these mechanisms and implementing appropriate nutritional strategies, the negative impact of corticosteroid-induced protein catabolism can be minimized, helping to preserve muscle mass and function during necessary corticosteroid therapy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.